| Detected | Trial | Change |
|---|---|---|
| 2026-08-11 | NCT06549855 PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd… |
Recruitment opened |
| 2026-08-09 | NCT06386120 Respiratory Function Monitoring of Mechanical Ventilation in Patients With Chest Blunt… |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-02 | NCT06518044 NAC for Hematopoietic Recovery in SAA |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-02 | NCT06479941 Antibiotic Exposure During Pregnancy Affects Infant Gut Microbiota |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT05675787 Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial… |
overall status: Recruiting → Unknown |
| 2026-07-29 | NCT07335887 Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With… |
Recruitment opened |
| 2026-07-29 | NCT07335887 Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With… |
Primary endpoint(s) modified |
| 2026-07-29 | NCT07335887 Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With… |
Trial sites expanded: 0 -> 3 locations |
| 2026-07-29 | NCT07335887 Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With… |
date change Primary completion moved earlier: 2028-02-29 -> 2027-12-31 |
| 2026-07-29 | NCT07335887 Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With… |
date change Completion moved earlier: 2029-01-31 -> 2028-08-31 |
| 2026-07-28 | NCT07654036 Preliminary Evaluation of a Large Language Model-Based Tool for Complex Surgical Decision… |
overall status: Enrolling by Invitation → Completed |
| 2026-07-28 | NCT07654036 Preliminary Evaluation of a Large Language Model-Based Tool for Complex Surgical Decision… |
Enrollment reduced: 12 -> 8 participants |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-12 | NCT07759284 Endotracheal Tube Intolerance and Respiratory Airflow Perception | Not Yet Recruiting | |
| 2026-07-30 | NCT07737262 Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in… | Phase 3 | Not Yet Recruiting |
| 2026-07-29 | NCT07733037 Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia | Phase 2 | Active, Not Recruiting |
| 2026-07-28 | NCT07730593 CBT-I for the Patients With Chronic Insomnia in China | Completed | |
| 2026-07-24 | NCT07725783 Prospective Evaluation of Dynamic Serum ProGRP for Treatment Response Monitoring in Ewing… | Recruiting | |
| 2026-07-23 | NCT07721558 Effect of Inspired Oxygen Concentration on Postoperative Atelectasis After VATS Lobectomy | Not Yet Recruiting | |
| 2026-07-22 | NCT07720011 Interim PET/CT-adapted Use of PD-1 Inhibitor Combined With De-escalated Chemotherapy-AVD… | Phase 2 | Completed |
| 2026-07-20 | NCT07714070 Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07600164 | Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer | HER2 + Breast Cancer | Recruiting |
| NCT07075250 | Safety and Efficacy of RIF Combined With Anlotinib in the Treatment of Patients With… | Platinum-resistant Ovarian Cancer (PROC) | Not Yet Recruiting |
| NCT06364319 | Efficacy and Safety of Anti-CD25 rhMAb in the Treatment of Steroid-Refractory cGVHD | cGVHD | Not Yet Recruiting |
| Phase 3 | |||
| NCT06802718 | Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid Leukemia | Acute Myeloid Leukemia | Recruiting |
| NCT05921305 | Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD | Acute Graft Versus Host Disease | Recruiting |
| NCT07441291 | CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT | B ALL | Recruiting |
| NCT05495321 | Interleukin-2 on Active Dermatomyositis | Dermatomyositis | Enrolling by Invitation |
| NCT07407660 | Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in… | Acute Myeloid Leukemia | Not Yet Recruiting |
| NCT07597395 | ATRA for Management of Primary ITP | Immune Thrombocytopenia | Not Yet Recruiting |
| NCT07737262 | Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in… | Aplastic Anemia | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT03793517 | Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT | Stem Cell Transplant Complications | Recruiting |
| NCT06202625 | Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT | Thrombocytopenia | Recruiting |
| NCT06879379 | KPD Consolidation After ASCT in NDMM Patients | Multiple Myeloma, Newly Diagnosed | Recruiting |
| Phase 2 | |||
| NCT06577909 | Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy | Immune Thrombocytopenia | Recruiting |
| NCT06418477 | Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with… | Monoclonal Gammopathy of Renal Significance | Recruiting |
| NCT06714383 | Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma | Osteosarcoma | Recruiting |
| NCT06794008 | BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases | Systemic Lupus Erythematosus | Recruiting |
| NCT06102863 | Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial… | Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I | Recruiting |
| NCT06869265 | Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical… | Acute Myeloid Leukemia (AML) | Recruiting |
| NCT06130579 | Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT | Myeloid Leukemia | Recruiting |
| NCT06984536 | Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT | Myelodysplastic Syndrome | Recruiting |
| NCT07065968 | The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly… | Immune Thrombocytopenia (ITP) | Recruiting |
| NCT07586813 | Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia… | Persistent Isolated Chemotherapy-Induced Thrombocytopenia | Recruiting |
| NCT07586826 | Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia… | Persistent Isolated Chemotherapy-Induced Thrombocytopenia | Recruiting |
| NCT06970912 | ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in… | Hormone Receptor-Positive Breast Cancer | Recruiting |